News & Media

AACR NextGen Star Kara Maxwell, MD, PhD, Basser Men & BRCA program director, was interviewed about her research on Li-Fraumeni Syndrome, a hereditary cancer predisposition syndrome associated with pathogenic germline TP53 alterations.

A study led by Roger Greenberg, MD, PhD, Basser Center director of Basic Science, identified a multi-protein “machine” in cells that helps govern the pausing of DNA replication.

Kara Maxwell, MD, PhD, Basser Center Men & BRCA program director, was selected for the 2024 AACR NextGen Stars Program.

Stacey Sager shares a series of stories as she takes us through her own courageous and challenging health journey as a BRCA1 gene mutation carrier, featuring Dr. Susan Domchek, the executive director at the Basser Center.

Susan Domchek, MD, executive director of the Basser Center, discusses the latest updates in the race for a cancer prevention vaccine that could benefit individuals and families carrying a BRCA1 or BRCA2 genetic mutation.

University of Pennsylvania researchers are studying a preventative vaccine for people who carry cancer-causing BRCA gene mutations, through a clinical trial with healthy participants.

A groundbreaking cancer vaccine is in the midst of clinical trials at the Basser Center. The shot would benefit those carrying cancer-causing BRCA gene mutations by recognizing early signs of disease and stopping cancer before it develops.

Robert Vonderheide, MD, DPhil, Abramson Cancer Center Director, describes the Basser Center's work on creating a vaccine for people at high risk for certain cancers as a potential “game changer.”

Basser genetic counselors, Jessica Long, MS, CGC, CGAF, and Danielle Mckenna, MS, CGC, and their team published a paper on Lynch syndrome. Similar work is underway to optimize electronic health record tools for BRCA-related medical management.

The Basser Center for BRCA won a Bronze Award in the “Print/Out-of-Home Campaign of the Year” category from the Healthcare Impact Awards, presented by Modern Healthcare and Ad Age.